Arch Therapeutics, Inc. ARTH
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 444
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- —
- High
- —
- Earnings
- Feb 12, 2025
News
9 months ago defenseworld.net
SANUWAVE Health (OTCMKTS:SNWV) and Arch Therapeutics (OTCMKTS:ARTH) Critical Review
Profitability This table compares Arch Therapeutics and SANUWAVE Health's net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Arch Therapeutics…
11 months ago defenseworld.net
Critical Comparison: Arch Therapeutics (OTCMKTS:ARTH) vs. Biostage (OTCMKTS:BSTG)
Arch Therapeutics (OTCMKTS:ARTH - Get Free Report) and Biostage (OTCMKTS:BSTG - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two…
2 years ago globenewswire.com
Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)
SAWC Fall provides a venue to educate clinicians about AC5 Advanced Wound System, present case studies, and continue strategic meetings with wound care companies. SAWC Fall provides a venue to…
2 years ago globenewswire.com
Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)
A Study of AC5® Advanced Wound System in Patients with Lower Extremity Wounds to be Featured in a Clinical Poster A Study of AC5® Advanced Wound System in Patients with Lower Extremity Wounds to be…
2 years ago zacks.com
Are Medical Stocks Lagging Arch Therapeutics (ARTH) This Year?
Here is how Arch Therapeutics, Inc. (ARTH) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.
2 years ago investorplace.com
7 Stock Winners That Are Up 1,000% or More in 2023
As you may already suspect, there are not a lot of stocks up 1000% year-to-date, but several stocks trading on major exchanges are up 1000% from their lows set earlier in the calendar year. There are…
2 years ago zacks.com
Are Medical Stocks Lagging Arch Therapeutics (ARTH) This Year?
Here is how Arch Therapeutics, Inc. (ARTH) and Haemonetics (HAE) have performed compared to their sector so far this year.
2 years ago zacks.com
Are Medical Stocks Lagging Arch Therapeutics (ARTH) This Year?
Here is how Arch Therapeutics, Inc. (ARTH) and Cardinal Health (CAH) have performed compared to their sector so far this year.
2 years ago globenewswire.com
Arch Therapeutics Provides Year End Operational Update
Fiscal year-end AC5 Advanced Wound System update includes Q4 record monthly order volumes, favorable reimbursement decisions and increases in paid claims.
3 years ago globenewswire.com
Arch Therapeutics to Present AC5® Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)
FRAMINGHAM, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today…
3 years ago globenewswire.com
Arch Therapeutics Provides AC5® Commercialization Update
Orders and Paid Claims Increasing Since Rollout of Reimbursement Code Orders and Paid Claims Increasing Since Rollout of Reimbursement Code
3 years ago globenewswire.com
Arch Therapeutics Completes Financing as Bridge to Uplisting
Common Stock Listing on National Exchange is Next Planned Significant Milestone Common Stock Listing on National Exchange is Next Planned Significant Milestone
3 years ago globenewswire.com
Arch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”)
SAWC Spring 2023 represents first clinical conference opportunity to introduce newly effective dedicated AC5 HCPCS reimbursement code SAWC Spring 2023 represents first clinical conference opportunity…
4 years ago globenewswire.com
Arch Therapeutics Accepted to Present AC5® Advanced Wound System During Innovation Spotlight at 2022 Symposium on Advanced Wound Care (SAWC)
Prestigious Honor Supports Increasing Interest in Broad Clinical Benefits of Synthetic Products in Wound Healing Prestigious Honor Supports Increasing Interest in Broad Clinical Benefits of Synthetic…
5 years ago globenewswire.com
Arch Therapeutics to Present AC5 Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC) Fall
AC5® Advanced Wound System Selected for Innovation Spotlight AC5® Advanced Wound System Selected for Innovation Spotlight
5 years ago globenewswire.com
Arch Therapeutics Launches Experts in Wound Care Program
Key Opinion Leaders Share Insights on Advancing Wound Care Key Opinion Leaders Share Insights on Advancing Wound Care
5 years ago globenewswire.com
Arch Therapeutics Provides Corporate Update
90-Day Report Card for Commercialization Effort
5 years ago globenewswire.com
Arch Therapeutics to Present at the LD Micro Main Event
In-Person Presentation on October 13, 2021 In-Person Presentation on October 13, 2021
5 years ago globenewswire.com
Arch Therapeutics Launches Coverage and Reimbursement Pilot
Critical Next Step in Commercialization Plan Commences Critical Next Step in Commercialization Plan Commences
5 years ago globenewswire.com
Arch Therapeutics Announces Appointment of Larry Hicks to the Board
Brings deep industry experience to support commercialization plan Brings deep industry experience to support commercialization plan
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
7 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
Stocks That Hit 52-Week Lows On Friday